Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Finasteride for hair loss may cause lasting sexual, genitourinary, mental, and anti-androgenic side effects in young men.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Finasteride 1mg linked to diverse symptoms; other treatments improve erectile function in rats.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

More research needed to confirm finasteride as standard treatment for FFA.

Finasteride and dutasteride can improve hair loss in women, but more research is needed.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

5-alpha reductase inhibitors don't increase breast cancer or benign breast disorder risk in women.

A higher genetic risk score increases the chance of getting benign prostatic hyperplasia and affects treatment outcomes in Han Chinese men.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Dutasteride is effective for treating hair loss.

Younger people (median age 35) experience more PFS-like symptoms with 1mg finasteride; more research needed.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Long-term medication for enlarged prostate might not clearly affect the timing or outcomes of later surgery.

More men are using medication for benign prostatic hyperplasia, influenced by marketing and FDA approvals.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Oral finasteride may cause more sexual side effects than expected, possibly due to negative publicity and reporting bias.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatments.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Post-finasteride syndrome can cause sexual and systemic side effects, and patients should be informed about these risks.

Finasteride may help treat female hair loss, but has risks.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

5-ARI therapy may help prevent prostate cancer progression.

Urologists should screen for mental health issues before and during finasteride treatment.